KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesReal Estate - NetReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthpeak Properties (DOC) Current Deferred Revenue (2016 - 2026)

Healthpeak Properties has reported Current Deferred Revenue over the past 17 years, most recently at $985.3 million for Q4 2025.

  • Quarterly Current Deferred Revenue rose 4.8% to $985.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $985.3 million through Dec 2025, up 4.8% year-over-year, with the annual reading at $985.3 million for FY2025, 4.8% up from the prior year.
  • Current Deferred Revenue was $985.3 million for Q4 2025 at Healthpeak Properties, up from $970.1 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $985.3 million in Q4 2025 and troughed at $765.9 million in Q1 2021.
  • The 5-year median for Current Deferred Revenue is $880.5 million (2023), against an average of $875.4 million.
  • Year-over-year, Current Deferred Revenue grew 1.66% in 2021 and then rose 8.24% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $789.2 million in 2021, then increased by 6.95% to $844.1 million in 2022, then grew by 7.29% to $905.6 million in 2023, then grew by 3.81% to $940.1 million in 2024, then increased by 4.8% to $985.3 million in 2025.
  • Per Business Quant, the three most recent readings for DOC's Current Deferred Revenue are $985.3 million (Q4 2025), $970.1 million (Q3 2025), and $965.8 million (Q2 2025).